Suppr超能文献

早产儿凝血酶生成试验检测到的促凝失衡。

Procoagulant imbalance in preterm neonates detected by thrombin generation procedures.

机构信息

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milano, Italy.

NICU, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

出版信息

Thromb Res. 2020 Jan;185:96-101. doi: 10.1016/j.thromres.2019.11.013. Epub 2019 Nov 15.

Abstract

Preterm newborns are considered at risk of acquired coagulopathy and are often prophylactically infused with fresh frozen plasma (FFP) even in the absence of bleeding. To assess the coagulation asset of preterm neonates and the biological plausibility of such infusions, we investigated at birth 87 very low birth weight (≤1500 g) preterm (gestational age <35 weeks) newborns and 64 full-term newborns. Preterm neonates were also investigated at different time-points up to 30 days after birth. Plasma from preterm and full-term neonates were subjected to the measurement of prothrombin and activated partial thromboplastin time (PT, APTT), pro- and anticoagulant factors as well as to thrombin-generation procedures both with and without thrombomodulin. PT and APTT of preterm newborns were longer than those of full-term neonates [PT: 15.9 s (11.7-51.2)-vs-13.8 (11.0-25.4), p < 0.001. APTT: 59.0 (37.8-97.5)-vs- 47.3 (28.1-71.9), p < 0.001] and tended to shortening after 30 days from birth. Thrombin-generation defined as endogenous thrombin potential (ETP) was increased in preterm as compared to full-term neonates at birth [1322 nM·min (474-2384)-vs-1006 (697-1612), p < 0.001] and did not change appreciably over time up to 30 days from birth. In conclusion, plasma from preterm neonates displays a procoagulant imbalance at birth as shown by increasing ETP, despite the prolongation of PT and APTT. The results define preterm newborns as having hyper- rather than hypo-coagulability and argue against the infusion of FFP when given prophylactically and/or based solely on prolongation of PT or APTT.

摘要

早产儿被认为有获得性凝血障碍的风险,即使没有出血,也经常预防性输注新鲜冷冻血浆(FFP)。为了评估早产儿的凝血状态和这种输注的生物学合理性,我们在出生时研究了 87 名极低出生体重(≤1500g)早产儿(胎龄<35 周)和 64 名足月新生儿。早产儿还在出生后不同时间点至 30 天进行了研究。将早产儿和足月新生儿的血浆进行凝血酶原和活化部分凝血活酶时间(PT、APTT)、促凝和抗凝因子以及有和没有血栓调节蛋白的凝血酶生成程序的测量。早产儿的 PT 和 APTT 长于足月新生儿[PT:15.9s(11.7-51.2)-vs-13.8(11.0-25.4),p<0.001。APTT:59.0(37.8-97.5)-vs-47.3(28.1-71.9),p<0.001],并在出生后 30 天有缩短趋势。凝血酶生成定义为内源性凝血酶潜能(ETP),与足月新生儿相比,早产儿在出生时增加[1322 nM·min(474-2384)-vs-1006(697-1612),p<0.001],并且在出生后 30 天内没有明显变化。总之,早产儿的血浆在出生时显示出促凝失衡,表现为 ETP 增加,尽管 PT 和 APTT 延长。这些结果定义早产儿为高凝而不是低凝,并反对预防性给予 FFP 以及/或仅基于 PT 或 APTT 延长的情况下给予 FFP。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验